We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

194 hedge funds and large institutions have $2.05B invested in Beam Therapeutics in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 78 increasing their positions, 47 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $16M | Put options by funds: $6.86M

66% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 47

11% more capital invested

Capital invested by funds: $1.85B → $2.05B (+$201M)

0.84% more ownership

Funds ownership: 83.39% → 84.24% (+0.84%)

6% less funds holding

Funds holding: 206 → 194 (-12)

35% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 31

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
194
Holders Change
-12
Holders Change %
-5.83%
% of All Funds
3.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
20
Increased
78
Reduced
47
Closed
31
Calls
$16M
Puts
$6.86M
Net Calls
+$9.17M
Net Calls Change
+$16.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$34.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$34.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$20.3M
4
NAMA
Nikko Asset Management Americas
New York
+$18.1M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$18.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$15.1M
2
Bank of America
Bank of America
North Carolina
-$6.47M
3
AIM
ARK Investment Management
Florida
-$6.19M
4
EC
EcoR1 Capital
California
-$6.08M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$268M -$6.19M -190,834 -2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$228M +$34.1M +1,050,156 +17%
Vanguard Group
3
Vanguard Group
Pennsylvania
$224M +$20.3M +624,488 +10%
BlackRock
4
BlackRock
New York
$203M +$34.4M +1,060,104 +20%
Temasek Holdings
5
Temasek Holdings
Singapore
$138M +$7.25M +223,277 +5%
State Street
6
State Street
Massachusetts
$115M +$11.4M +350,916 +11%
FCM
7
Farallon Capital Management
California
$110M +$312K +9,601 +0.3%
MM
8
MWG Management
British Virgin Islands
$74.9M – – –
RG
9
Redmile Group
California
$47.4M -$4.12M -126,895 -8%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$42.3M +$3.95M +121,846 +10%
DTC
11
Deep Track Capital
Connecticut
$42.1M +$2.18M +67,316 +5%
NAMA
12
Nikko Asset Management Americas
New York
$38.8M +$18.1M +556,514 +85%
Sumitomo Mitsui Trust Group
13
Sumitomo Mitsui Trust Group
Japan
$38.8M +$18.1M +556,514 +85%
Morgan Stanley
14
Morgan Stanley
New York
$26.7M +$3.41M +105,064 +14%
HH
15
HSG Holding
Hong Kong
$25.4M – – –
Goldman Sachs
16
Goldman Sachs
New York
$23.2M +$2.2M +67,767 +10%
JP Morgan Chase
17
JP Morgan Chase
New York
$22.6M -$469K -14,455 -2%
PAMS
18
Pictet Asset Management (Switzerland)
Switzerland
$22.4M +$10.2M +315,042 +81%
BG
19
Bellevue Group
Switzerland
$22.2M – – –
Northern Trust
20
Northern Trust
Illinois
$20M +$552K +16,998 +3%
CC
21
Casdin Capital
New York
$18.2M – – –
Baillie Gifford & Co
22
Baillie Gifford & Co
United Kingdom
$16.7M +$2.3M +70,972 +16%
Charles Schwab
23
Charles Schwab
California
$16M +$1.23M +37,806 +8%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$15.4M +$177K +5,463 +1%
YCM
25
Yiheng Capital Management
California
$14.8M – – –
1
2 3 4 5

BEAM Hedge Fund Activity: Q2 2023 in Review

194 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2023, worth a combined $2.05B — up 11% from $1.85B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of BEAM and 20 opened new positions — a net loss of 11 holders — while 47 trimmed existing stakes and 78 added.

The largest buyer was BlackRock, adding an estimated $34.4M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $15.1M sold.

  • 194 institutional investors held Beam Therapeutics (BEAM) as of Q2 2023, down from 206 in Q1 2023.
  • Funds reported $2.05B of Beam Therapeutics stock for Q2 2023, up 11% quarter-over-quarter.
  • 20 funds opened new Beam Therapeutics positions in Q2 2023 and 31 closed out, a net change of -11 holders.
  • The largest Beam Therapeutics buyer in Q2 2023 was BlackRock, an estimated $34.4M added.
  • The largest Beam Therapeutics seller in Q2 2023 was Capital Research Global Investors, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2023.